Home

Joseph Truitt

CIK 1452429 · Chief Executive Officer · last filed 2026-09-10

Joseph Truitt is a Chief Executive Officer who has filed 29 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for IPSC, was dated Sep 10, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.6K

Companies

5

Total Filings

29

Lifetime Open-Market Net

-$1.10M

Filer Profile

Reported Address
C/O ACHILLION PHARMACEUTICALS, INC.
300 GEORGE STREET
NEW HAVEN, CT 06511
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IPSC Director — $1.76 — $0 1 2026-09-10
LRMR Director 2,750 $3.87 $10.6K $10.3K 8 2026-05-20
BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted Chief Executive Officer — — — $0 3 2020-12-02
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Chief Executive Officer 0 — — -$1.11M 16 2020-01-29
ACHILLION PHARMACEUTICALS INC (TPTX) Delisted VP, Chief Commercial Officer — $76.01 — $0 1 2009-01-07

Recent Filings

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-10 IPSC Grant (A) — $0 EDGAR
2026-05-20 LRMR Grant (A) — $0 EDGAR
2025-05-14 LRMR Grant (A) — $0 EDGAR
2024-05-31 LRMR Grant (A) — $0 EDGAR
2023-05-18 LRMR Buy (P) +2,750 $10.3K EDGAR
2023-05-11 LRMR Grant (A) — $0 EDGAR
2022-05-12 LRMR Grant (A) — $0 EDGAR
2021-05-20 LRMR Grant (A) — $0 EDGAR
2020-12-02 BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted Disp (D) — $0 EDGAR
2020-10-19 BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 29
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.